HER2 Support Group Forums - View Single Post - ImmunoGen, Inc. Announces Start Of SAR566658 Clinical Testing

News · 09-23-2010, 06:10 AM

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, announced the start of clinical testing with SAR566658...

More...

09-23-2010, 06:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,985	ImmunoGen, Inc. Announces Start Of SAR566658 Clinical Testing ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, announced the start of clinical testing with SAR566658... More...